Lara Wagner1, Fabrice F Darche1,2, Dierk Thomas1,2,3, Patrick Lugenbiel1,2, Panagiotis Xynogalos1,2, Svenja Seide4, Eberhard P Scholz1,2,3, Hugo A Katus1,2,3, Patrick A Schweizer5,6,7. 1. Department of Cardiology, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany. 2. Heidelberg Center for Heart Rhythm Disorders (HCR), University Hospital Heidelberg, Heidelberg, Germany. 3. DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany. 4. Institute of Medical Biometry and Informatics, University of Heidelberg, INF 130.3, 69120, Heidelberg, Germany. 5. Department of Cardiology, University Hospital Heidelberg, INF 410, 69120, Heidelberg, Germany. patrick.schweizer@med.uni-heidelberg.de. 6. Heidelberg Center for Heart Rhythm Disorders (HCR), University Hospital Heidelberg, Heidelberg, Germany. patrick.schweizer@med.uni-heidelberg.de. 7. DZHK (German Centre for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany. patrick.schweizer@med.uni-heidelberg.de.
Abstract
BACKGROUND: Modulation of the cardiac autonomic nervous system by pulmonary vein isolation (PVI) influences the sinoatrial nodal rate. Little is known about the causes, maintenance and prognostic value of this phenomenon. We set out to explore the effects of cryoballoon PVI (cryo-PVI) on sinus rate and its significance for clinical outcome. METHODS AND RESULTS: We evaluated 110 patients with paroxysmal atrial fibrillation (AF), who underwent PVI using a second-generation 28 mm cryoballoon by pre-, peri- and postprocedural heart rate acquisition and analysis of clinical outcome. Ninety-one patients could be included in postinterventional follow-up, indicating that cryo-PVI resulted in a significant rise of sinus rate by 16.5% (+ 9.8 ± 0.9 beats/min, p < 0.001) 1 day post procedure compared to preprocedural acquisition. This effect was more pronounced in patients with initial sinus bradycardia (< 60 beats/min.) compared to patients with faster heart rate. Increase of rate was primarily driven by ablation of the right superior pulmonary vein and for a subset of patients, in whom this could be assessed, persisted ≥ 1 year after the procedure. AF recurrence was neither predicted by the magnitude of the initial rate, nor by the extent of rate change, but postprocedural sinus bradycardia was associated with higher recurrence of AF in the year post PVI. CONCLUSIONS: Cryo-PVI causes a significant rise of sinus rate that is more pronounced in subjects with previous sinus bradycardia. Patient follow-up indicates persistence of this effect and suggests an increased risk of AF recurrence in patients with postprocedural bradycardia.
BACKGROUND: Modulation of the cardiac autonomic nervous system by pulmonary vein isolation (PVI) influences the sinoatrial nodal rate. Little is known about the causes, maintenance and prognostic value of this phenomenon. We set out to explore the effects of cryoballoon PVI (cryo-PVI) on sinus rate and its significance for clinical outcome. METHODS AND RESULTS: We evaluated 110 patients with paroxysmal atrial fibrillation (AF), who underwent PVI using a second-generation 28 mm cryoballoon by pre-, peri- and postprocedural heart rate acquisition and analysis of clinical outcome. Ninety-one patients could be included in postinterventional follow-up, indicating that cryo-PVI resulted in a significant rise of sinus rate by 16.5% (+ 9.8 ± 0.9 beats/min, p < 0.001) 1 day post procedure compared to preprocedural acquisition. This effect was more pronounced in patients with initial sinus bradycardia (< 60 beats/min.) compared to patients with faster heart rate. Increase of rate was primarily driven by ablation of the right superior pulmonary vein and for a subset of patients, in whom this could be assessed, persisted ≥ 1 year after the procedure. AF recurrence was neither predicted by the magnitude of the initial rate, nor by the extent of rate change, but postprocedural sinus bradycardia was associated with higher recurrence of AF in the year post PVI. CONCLUSIONS: Cryo-PVI causes a significant rise of sinus rate that is more pronounced in subjects with previous sinus bradycardia. Patient follow-up indicates persistence of this effect and suggests an increased risk of AF recurrence in patients with postprocedural bradycardia.
Authors: Verena Semmler; Felix von Krogh; Bernhard Haller; Tilko Reents; Felix Bourier; Marta Telishevska; Marc Kottmaier; Marielouise Kornmayer; Stephanie Brooks; Katharina Koch-Büttner; Carsten Lennerz; Amir Brkic; Christian Grebmer; Patrick Blazek; Severin Weigand; Gabriele Hessling; Christof Kolb; Isabel Deisenhofer Journal: Clin Res Cardiol Date: 2018-11-20 Impact factor: 5.460
Authors: Dierk Thomas; Eberhard P Scholz; Patrick A Schweizer; Hugo A Katus; Rüdiger Becker Journal: J Electrocardiol Date: 2011-06-28 Impact factor: 1.438
Authors: Erik Wissner; Christian-Hendrik Heeger; Hanno Grahn; Bruno Reissmann; Peter Wohlmuth; Christine Lemes; Peter Rausch; Shibu Mathew; Andreas Rillig; Sebastian Deiss; Tillman Maurer; Tina Lin; Roland Richard Tilz; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: Europace Date: 2015-04-12 Impact factor: 5.214
Authors: M Haïssaguerre; P Jaïs; D C Shah; A Takahashi; M Hocini; G Quiniou; S Garrigue; A Le Mouroux; P Le Métayer; J Clémenty Journal: N Engl J Med Date: 1998-09-03 Impact factor: 91.245
Authors: Maura M Zylla; Johannes Brachmann; Thorsten Lewalter; Ellen Hoffmann; Karl-Heinz Kuck; Dietrich Andresen; Stephan Willems; Matthias Hochadel; Jochen Senges; Hugo A Katus; Dierk Thomas Journal: J Electrocardiol Date: 2015-12-24 Impact factor: 1.438
Authors: Karl-Heinz Kuck; Josep Brugada; Alexander Fürnkranz; Andreas Metzner; Feifan Ouyang; K R Julian Chun; Arif Elvan; Thomas Arentz; Kurt Bestehorn; Stuart J Pocock; Jean-Paul Albenque; Claudio Tondo Journal: N Engl J Med Date: 2016-04-04 Impact factor: 91.245
Authors: Gesa von Olshausen; Ott Saluveer; Jonas Schwieler; Nikola Drca; Hamid Bastani; Jari Tapanainen; Tara Bourke; Astrid Paul-Nordin; Göran Kennebäck; Per Insulander; Mats Jensen-Urstad; Frieder Braunschweig Journal: Clin Res Cardiol Date: 2020-11-12 Impact factor: 5.460